Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
9103.TW Stock Summary
In the News
9103.TW Financial details
Company Rating
Sell
Market Cap
3.84B
Income
-35.68M
Revenue
141.63M
Book val./share
0.27
Cash/share
0.06
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
-5.38
Forward P/E
-
PEG
0.18
P/S
1.32
P/B
1.05
P/C
116
P/FCF
-3.11
Quick Ratio
2.62
Current Ratio
4.31
Debt / Equity
0.17
LT Debt / Equity
0.02
-
-
EPS (TTM)
-0.07
EPS next Y
-
EPS next Q
-
EPS this Y
-269.4%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-3.81%
Revenue Q/Q
7.71%
EPS Q/Q
-78.56%
-
-
-
-
SMA20
-12.5%
SMA50
-22.22%
SMA100
16.67%
Inst Own
0%
Inst Trans
0%
ROA
-16%
ROE
-17%
ROC
-0.19%
Gross Margin
-6%
Oper. Margin
-53%
Profit Margin
-52%
Payout
-11%
Shs Outstand
544.91M
Shs Float
477.04M
-
-
-
-
Target Price
-
52W Range
5.63-10.0
52W High
-30.4%
52W Low
+39.2%
RSI
42
Rel Volume
0.07
Avg Volume
3.36M
Volume
250.73K
Perf Week
-3.87%
Perf Month
-1.69%
Perf Quarter
12.44%
Perf Half Y
10.3%
-
-
-
-
Beta
1.225
-
-
Volatility
0.17%, 0.35%
Prev Close
0.29%
Price
6.96
Change
3.88%
9103.TW Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.12 | 0.13 | 0.73 | 0.26 | 0.1 | |
Net income per share | 0 | 0 | 0.24 | 0.03 | -0.05 | |
Operating cash flow per share | 0.01 | 0.01 | 0.18 | 0.05 | -0.01 | |
Free cash flow per share | 0 | 0 | 0.17 | 0.02 | -0.04 | |
Cash per share | 0.02 | 0.01 | 0.16 | 0.11 | 0.06 | |
Book value per share | 0.11 | 0.12 | 0.35 | 0.34 | 0.27 | |
Tangible book value per share | 0.11 | 0.12 | 0.35 | 0.34 | 0.28 | |
Share holders equity per share | 0.11 | 0.12 | 0.35 | 0.34 | 0.27 | |
Interest debt per share | 0.08 | 0.09 | 0.07 | 0.03 | 0.04 | |
Market cap | 21.56M | 22.37M | 576.39M | 278.81M | 145.28M | |
Enterprise value | 57.85M | 65.4M | 530.85M | 246.66M | 146.72M | |
P/E ratio | 23.59 | 19.25 | 4.38 | 16.08 | -4.96 | |
Price to sales ratio | 0.32 | 0.32 | 1.44 | 1.93 | 2.58 | |
POCF ratio | 3.83 | 5.12 | 5.67 | 9.37 | -35.85 | |
PFCF ratio | 68.22 | -110.76 | 6.19 | 20.83 | -6.1 | |
P/B Ratio | 0.35 | 0.35 | 2.98 | 1.51 | 0.97 | |
PTB ratio | 0.35 | 0.35 | 2.98 | 1.51 | 0.97 | |
EV to sales | 0.85 | 0.95 | 1.33 | 1.71 | 2.61 | |
Enterprise value over EBITDA | 7.32 | 6.81 | 3.67 | 10.12 | -6.2 | |
EV to operating cash flow | 10.28 | 14.97 | 5.23 | 8.29 | -36.2 | |
EV to free cash flow | 183.08 | -323.78 | 5.7 | 18.43 | -6.16 | |
Earnings yield | 0.04 | 0.05 | 0.23 | 0.06 | -0.2 | |
Free cash flow yield | 0.01 | -0.01 | 0.16 | 0.05 | -0.16 | |
Debt to equity | 0.65 | 0.73 | 0.19 | 0.09 | 0.13 | |
Debt to assets | 0.36 | 0.4 | 0.15 | 0.08 | 0.11 | |
Net debt to EBITDA | 4.59 | 4.48 | -0.31 | -1.32 | -0.06 | |
Current ratio | 1.74 | 1.82 | 4.48 | 7.92 | 4.31 | |
Interest coverage | 1.46 | 1.66 | 91.91 | 20.79 | -36.73 | |
Income quality | 4.74 | 2.88 | 0.75 | 1.76 | 0.13 | |
Dividend Yield | 0 | 0 | 0.01 | 0.08 | 0.02 | |
Payout ratio | 0 | 0 | 0.04 | 1.32 | -0.11 | |
Sales general and administrative to revenue | 0.07 | 0.07 | 0.03 | 0.1 | 0.32 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0.01 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.94 | -1.05 | -0.08 | -0.55 | 4.88 | |
Capex to revenue | -0.08 | -0.07 | -0.02 | -0.11 | -0.35 | |
Capex to depreciation | -1.07 | -0.79 | -1.04 | -2.47 | -3.09 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.07 | 0.07 | 1.38 | 0.49 | 0.58 | |
ROIC | 0.02 | 0.03 | 0.57 | 0.08 | -0.17 | |
Return on tangible assets | 0.01 | 0.01 | 0.54 | 0.08 | -0.16 | |
Graham Net | -0.02 | -0.03 | 0.18 | 0.16 | 0.09 | |
Working capital | 31.65M | 33.89M | 160.07M | 142.74M | 83.06M | |
Tangible asset value | 62.64M | 63.88M | 193.78M | 187.2M | 151.61M | |
Net current asset value | 24.9M | 23.28M | 154.86M | 135.7M | 78.4M | |
Invested capital | 0.65 | 0.73 | 0.19 | 0.09 | 0.13 | |
Average receivables | 15.02M | 14.04M | 31.33M | 45.83M | 36.35M | |
Average payables | 3.23M | 1.92M | 3.48M | 5.29M | 3.19M | |
Average inventory | 34.08M | 35.85M | 45.76M | 51.67M | 43.03M | |
Days sales outstanding | 78.7 | 70.61 | 44.96 | 107.22 | 197.01 | |
Days payables outstanding | 18.19 | 5.92 | 9.58 | 16.34 | 11.12 | |
Days of inventory on hand | 212.95 | 236.34 | 85.67 | 177.49 | 222.96 | |
Receivables turnover | 4.64 | 5.17 | 8.12 | 3.4 | 1.85 | |
Payables turnover | 20.06 | 61.65 | 38.1 | 22.34 | 32.83 | |
Inventory turnover | 1.71 | 1.54 | 4.26 | 2.06 | 1.64 | |
ROE | 0.01 | 0.02 | 0.68 | 0.09 | -0.2 | |
Capex per share | -0.01 | -0.01 | -0.02 | -0.03 | -0.04 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2021-06-30 | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.16 | 0.11 | 0.06 | 0.05 | 0.05 | |
Net income per share | 0.03 | 0 | -0.01 | -0.05 | -0.01 | |
Operating cash flow per share | 0.04 | 0.01 | -0.03 | -0.01 | -0.01 | |
Free cash flow per share | 0.04 | -0.01 | -0.04 | -0.03 | -0.02 | |
Cash per share | 0.11 | 0.11 | 0.11 | 0.06 | 0.06 | |
Book value per share | 0.34 | 0.34 | 0.32 | 0.27 | 0.27 | |
Tangible book value per share | 0.34 | 0.34 | 0.33 | 0.28 | 0.27 | |
Share holders equity per share | 0.34 | 0.34 | 0.32 | 0.27 | 0.27 | |
Interest debt per share | 0.03 | 0.03 | 0.07 | 0.04 | 0.04 | |
Market cap | 429.93M | 278.55M | 141.47M | 145.18M | 115.93M | |
Enterprise value | 383.68M | 246.4M | 138.89M | 146.62M | 125.13M | |
P/E ratio | 5.64 | -40.39 | -9.56 | -1.46 | -5.41 | |
Price to sales ratio | 5.04 | 4.73 | 4.48 | 5.89 | 4.37 | |
POCF ratio | 17.58 | 49.34 | -9.65 | -40.27 | -14.82 | |
PFCF ratio | 20.91 | -40.8 | -6.42 | -9.08 | -12.48 | |
P/B Ratio | 2.3 | 1.5 | 0.81 | 0.97 | 0.8 | |
PTB ratio | 2.3 | 1.5 | 0.81 | 0.97 | 0.8 | |
EV to sales | 4.5 | 4.19 | 4.39 | 5.95 | 4.71 | |
Enterprise value over EBITDA | 18.83 | -359.71 | -59.1 | -5.34 | -28.33 | |
EV to operating cash flow | 15.69 | 43.65 | -9.48 | -40.67 | -15.99 | |
EV to free cash flow | 18.66 | -36.09 | -6.3 | -9.17 | -13.47 | |
Earnings yield | 0.04 | -0.01 | -0.03 | -0.17 | -0.05 | |
Free cash flow yield | 0.05 | -0.02 | -0.16 | -0.11 | -0.08 | |
Debt to equity | 0.08 | 0.09 | 0.21 | 0.13 | 0.17 | |
Debt to assets | 0.07 | 0.08 | 0.16 | 0.11 | 0.13 | |
Net debt to EBITDA | -2.27 | 46.94 | 1.1 | -0.05 | -2.08 | |
Current ratio | 9.49 | 7.92 | 6.34 | 4.31 | 3.67 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 1.28 | -3.27 | 3.96 | 0.14 | 1.46 | |
Dividend Yield | 0.05 | 0 | 0.02 | 0 | 0 | |
Payout ratio | 1.2 | 0 | -0.82 | -0.01 | 0 | |
Sales general and administrative to revenue | 0.07 | 0.14 | 0.23 | 0.42 | 0.27 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.16 | -2.21 | 0.5 | 3.43 | 0.19 | |
Capex to revenue | -0.05 | -0.21 | -0.23 | -0.5 | -0.06 | |
Capex to depreciation | -1.88 | -5.15 | -3.66 | -5.17 | -0.56 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.52 | 0.16 | 0.22 | 0.53 | 0.24 | |
ROIC | 0.09 | -0.01 | -0.02 | -0.17 | -0.04 | |
Return on tangible assets | 0.09 | -0.01 | -0.02 | -0.14 | -0.03 | |
Graham Net | 0.18 | 0.16 | 0.12 | 0.09 | 0.07 | |
Working capital | 152.75M | 142.74M | 135.68M | 83.06M | 80.65M | |
Tangible asset value | 186.48M | 187.2M | 177.82M | 151.61M | 146.25M | |
Net current asset value | 148.16M | 135.7M | 112.11M | 78.4M | 76.1M | |
Invested capital | 0.08 | 0.09 | 0.21 | 0.13 | 0.17 | |
Average receivables | 48.46M | 44.98M | 40.95M | 34.95M | 29.55M | |
Average payables | 4.57M | 3.85M | 6.65M | 5.27M | 4.18M | |
Average inventory | 51.81M | 49.8M | 49.17M | 42.54M | 37.96M | |
Days sales outstanding | 50.23 | 64.76 | 112.62 | 110.89 | 97.47 | |
Days payables outstanding | 5.18 | 8.92 | 33.93 | 4.76 | 26.45 | |
Days of inventory on hand | 82.43 | 96.85 | 189.35 | 95.45 | 159.64 | |
Receivables turnover | 1.79 | 1.39 | 0.8 | 0.81 | 0.92 | |
Payables turnover | 17.39 | 10.09 | 2.65 | 18.91 | 3.4 | |
Inventory turnover | 1.09 | 0.93 | 0.48 | 0.94 | 0.56 | |
ROE | 0.1 | -0.01 | -0.02 | -0.17 | -0.04 | |
Capex per share | -0.01 | -0.02 | -0.01 | -0.02 | 0 |
9103.TW Frequently Asked Questions
What is Medtecs International Corporation Limited stock symbol ?
Medtecs International Corporation Limited is a TW stock and trading under the symbol 9103.TW
What is Medtecs International Corporation Limited stock quote today ?
Medtecs International Corporation Limited stock price is $6.96 today.
Is Medtecs International Corporation Limited stock public?
Yes, Medtecs International Corporation Limited is a publicly traded company.